Skip to main content

Epoprostenol Injection and Sterile Diluent Shortage

Last Updated: July 14, 2023
Status: Current

Products Affected - Description
    • Epoprostenol sodium lyophilized powder for injection, Teva, 0.5 mg, single dose vial, NDC 00703-1985-01 - discontinued
    • Epoprostenol sodium lyophilized powder for injection, Teva, 1.5 mg, single dose vial, NDC 00703-1995-01 - discontinued
    • Sterile diluent for epoprostenol sodium, Teva, 94 mg glycine - 73.5 mg sodium chloride / 50 mL, 50 mL vial, 2 count, NDC 00703-9258-09 - discontinued
Reason for the Shortage
    • Actelion Pharmaceuticals has Veletri available through specialty distributors.
    • GSK has Flolan available. The pH 12 Sterile Diluent for Flolan is available through Curascript specialty pharmacy.
    • Sun Pharma has epoprostenol injection available.
    • Teva discontinued epoprostenol injection and sterile diluent in July 2023.
Available Products
    • Flolan lyophilized powder for injection, GSK, 0.5 mg, single dose vial, NDC 00173-0517-00
    • Flolan lyophilized powder for injection, GSK, 1.5 mg, single dose vial, NDC 00173-0519-00
    • Veletri lyophilized powder for injection, Actelion Pharmaceuticals, 0.5 mg, single dose vial, NDC 66215-0403-01
    • Veletri lyophilized powder for injection, Actelion Pharmaceuticals, 1.5 mg, single dose vial, NDC 66215-0402-01
    • Epoprostenol sodium lyophilized powder for injection, Sun Pharma, 0.5 mg, single dose vial, NDC 62756-0059-40
    • Epoprostenol sodium lyophilized powder for injection, Sun Pharma, 1.5 mg, single dose vial, NDC 62756-0060-40
    • pH 12 Sterile Diluent for Flolan, GSK, 94 mg glycine - 73.5 mg sodium chloride / 50 mL, 50 mL vial, 2 count, NDC 00173-0857-02

Updated

Updated July 14, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 15, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.